Thalassaemia: open trials in Belgium

• NCT04208529

  A Long-term Follow-up Study in Participants Who Received CTX001

  Trial Treatment · Phase 3 · Vertex Pharmaceuticals Incorporated

  Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola, Brussels

  Registry updated 2026-08-11

• NCT04064060

  A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

  Trial Treatment · Phase 3 · Celgene

  Brasschaat · Bruges · Ghent · Leuven

  Registry updated 2026-07-01

All Thalassaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error